S90 have CHD [odds ratio (OR) = 0.38, 95% confidence interval (CI): 0.16 0.86]. However, after adjustment for gender or smoking, there was little evidence that coronary heart disease was associated with DASH diet score. There was a significant negative correlation between DASH score and diastolic blood pressure (P 0.05). Conclusion: In conclusion, having a diet similar to DASH plan was not independently related to CHD in this study. This might indicate that having a healthy dietary pattern, such as DASH pattern, is highly related to gender (dietary pattern is healthier in women than men) or smoking habit (non-smokers have healthier dietary pattern compared to smokers).
Poster presentations SUN-PP180 THE VISUAL OR VERBAL ANALOGUE SCALE SEFI® (SIMPLIFIED EVALUATION OF FOOD INTAKE) SEFI® DETECTS THE INSUFFICIENT FOOD INTAKE: A SUBSTUDY OF NUTRITIONDAY® IN ONE UNIVERSITY HOSPITAL A.-M. Makhlouf1 , M. Chikhi1 , A. Mulliez2 , J. Depeyre3 , C. Pichard1 , R. Thibault1,4 . 1 Nutrition Unit, University Hospital of Geneva, Geneva, Switzerland; 2 Clinical research and innovation, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France; 3 Nutrition and Dietetic Department, HES-SO, Geneva, Switzerland; 4 Nutritional and digestive rehabilitation, Clinique Saint-Yves, Rennes, France
Disclosure of Interest: None declared
Nutritional assessment 1 SUN-PP179 SARCOPENIA AND LENGTH OF HOSPITAL STAY A.S. Sousa1 , R.S. Guerra2,3 , I. Fonseca4 , F. Pichel4 , T.F. Amaral1,3 . 1 Faculdade de Ciˆ encias da Nutri¸ca ˜o e Alimenta¸ca ˜o da Universidade do Porto, 2 Departamento de Bioquímica, Faculdade de Medicina da Universidade do Porto, 3 UISPA-INEGI, Faculdade de Engenharia da Universidade do Porto, 4 Servi¸co de Nutri¸ca ˜o e Alimenta¸ca ˜o, Centro Hospitalar do Porto, Porto, Portugal Rationale: Data on the impact of sarcopenia on length of hospital stay (LOS) are scarce and there is no information among hospitalized younger patients. This study aims to quantify the association of sarcopenia with LOS and to identify factors associated with sarcopenia among a wide-ranging sample of hospitalized patients. Methods: A longitudinal study was conducted. Sarcopenia was defined, according to European Consensus criteria, as low muscle mass (bioelectrical impedance analysis) and low muscle function (handgrip strength). Logistic regression, Kaplan Meier and Cox adjusted proportional hazards regression methods were used. LOS was determined from the date of hospital admission and discharge home (the event of interest). Results: 655 hospitalized patients aged 18 to 90 years (24.3% sarcopenic) composed the study sample. Factors associated with sarcopenia were male gender, age 65 years, moderate or severe dependence, under nutrition and being admitted to a medical ward. Sarcopenic patients presented a lower probability of being discharged home [Hazard Ratio (HR) = 0.71, 95% Confidence Interval (CI) 0.58 0.86]. However, after stratifying for age groups, this effect was visible only in patients aged <65 years (HR = 0.66, 95% CI 0.51 0.86). Moreover, sarcopenic overweight or obese patients presented a higher probability of being discharged home (HR = 0.78, 95% CI 0.61 0.99) than non-overweight sarcopenic patients (HR = 0.63, 95% CI 0.48 0.83). Conclusion: Being male, aged 65 years, presenting moderate or severe dependence, being undernourished and being admitted to a medical ward were factors associated with sarcopenia among hospitalized patients. Sarcopenia is independently associated with longer LOS, although this association is stronger for patients aged <65 years. Moreover, sarcopenic overweight was associated with a higher probability of discharge home than non-overweight sarcopenia. Disclosure of Interest: None declared
Rationale: The assessment of food intake (FI) can be done easily using the visual or verbal analogue scale SEFI® [1]. NutritionDay (ND)® survey assesses at hospital the FI during one day. We aim to: demonstrate the feasibility of the SEFI® by inexperienced care providers; compare the FI evaluation by SEFI® and ND® ; determine the relation between SEFI® score and criteria of nutritional risk and clinical outcome assessment. Methods: ND® was performed in 6 short stay units. Simultaneously to the FI assessment (0, 41 , 12 , 1) and ND® , 12 dietetic students evaluated FI on a 0 10 point scale using SEFI® . The visual scale was preferred to the verbal scale. Data on weight, weight loss, body mass index (BMI), hospital length of stay, readmission and 1-month mortality were collected. ROC curve and Youden’s index determined the cut-off of SEFI® associated with insufficient FI (<1 portion). Other variables were compared between patients with a SEFI® score <7 or 7 using c2 or Mann Whitney test. Results: Out of 89 patients, ND® and SEFI® were performed in 64 and 61 patients respectively. Visual scale, n = 53. SEFI® feasibility was 95.3%. Sensitivity (Se), specificity (Spe), positive (PPV) and negative (NPV) predictive values for SEFI® score <8 to predict an insufficient FI at lunch were 78%, 79%, 69% and 86% respectively (AUC = 0.87 [0.78 0.95]). Se, Spe, PPV and NPV for SEFI® score <7 to predict insufficient FI the week before ND® were 80%, 67%, 71% and 77%, respectively (AUC = 0.77 [0.64 0.89]). SEFI® score was associated with weight loss (<7, 51.9% vs 7, 29.4%, P < 0.001) whereas the other outcomes were not. Conclusion: In hospitalized patients, SEFI® is feasible in clinical routine, even by inexperienced care providers. SEFI® seems to be a reliable tool to identify insufficient food intake and nutritional risk. References [1] Thibault R, et al. Clin Nutr 2009; 28: 134 140. Disclosure of Interest: None declared